NYSE:FICO
NYSE:FICOSoftware

Taking Another Look at Fair Isaac (FICO)’s Valuation After Its Recent Share Price Rebound

Fair Isaac (FICO) has been quietly grinding higher, with shares up around 3% over the past month and roughly 15% in the past 3 months, even as year-to-date returns remain negative. See our latest analysis for Fair Isaac. That recent 15% 3 month share price return looks more like a constructive reset than a dead cat bounce, especially when you set it against the stock’s negative year to date share price performance, but very strong five year total shareholder return. If FICO’s move has you...
NasdaqGS:ROP
NasdaqGS:ROPSoftware

Roper Technologies (ROP): Has the Recent Share Price Slide Opened a Valuation Opportunity?

Roper Technologies (ROP) has been drifting lower this year, with shares down about 14% year to date even as revenue and net income keep growing at a steady high single digit pace. See our latest analysis for Roper Technologies. That slide has left Roper with a roughly 13.6% year to date share price decline and a weaker 1 year total shareholder return. This suggests investors are reassessing how much they will pay for its steady but unspectacular growth profile. If Roper’s softer momentum has...
NasdaqGS:INCY
NasdaqGS:INCYBiotechs

Is Incyte’s 2025 Surge Justified by Cash Flow Outlook and Oncology Pipeline Progress?

Wondering if Incyte is still a smart buy after its big run, or if most of the upside is already priced in? This breakdown will help you decide whether the current share price offers real value or just story driven momentum. Incyte's stock is up 39.8% over the past year and 39.6% year to date, even after a recent 6.8% slide over the last month and a modest 2.0% bump in the last week around the $97.03 level. This suggests investors may be reassessing both its growth potential and risk...
NasdaqGS:CLOV
NasdaqGS:CLOVHealthcare

Clover Health Investments (CLOV): Is the Market Undervaluing Its Tentative Share Price Recovery?

Clover Health Investments (CLOV) has quietly shifted gears this year, with the stock up around 7% over the past month even as its past 3 months performance remains negative. See our latest analysis for Clover Health Investments. That recent 6.9% 1 month share price return sits against a weak year to date share price performance and a still negative 1 year total shareholder return, suggesting sentiment is tentatively improving but far from fully convinced. If Clover’s move has you rethinking...
NYSE:NGL
NYSE:NGLOil and Gas

Has NGL Energy Partners’ Triple Digit Run in 2025 Already Priced In the Upside?

Wondering if NGL Energy Partners is still a bargain after such a massive run up, or if most of the easy money has already been made? This is exactly the kind of stock where valuation really matters. The unit price has cooled slightly in the short term, down around 3.2% over the last week and 2.1% over the past month, but it is still up about 85.7% year to date and roughly 100% over the last year, with a 736.5% gain over three years. Those kinds of moves have been driven by a mix of improving...
NasdaqGS:CTSH
NasdaqGS:CTSHIT

Can Cognizant Still Offer Value After Recent 3.3% Weekly and 59.6% Three Year Gains?

If you have been wondering whether Cognizant Technology Solutions is still worth buying at around $83.63, you are not alone; this stock has quietly become a classic "is it still good value" candidate. The share price has climbed 3.3% over the last week, 15.2% in the past month, and 9.4% year to date, while longer term holders have seen gains of 59.6% over three years and 11.5% over five years. Recently, investors have been reacting to a steady drumbeat of strategy updates, major client wins,...
NYSE:RKT
NYSE:RKTDiversified Financial

Rocket Companies (RKT): Reassessing Valuation After Google Tests New Home Listings Feature

Rocket Companies (RKT) slipped about 4% after Google started testing a home listings feature, stirring fresh competition worries in online real estate and prompting investors to reassess Rocket’s long term positioning. See our latest analysis for Rocket Companies. Zooming out, that Google headline landed after a strong run, with Rocket’s share price still up sharply on a year to date basis and a three year total shareholder return above 150 percent, suggesting momentum has cooled lately but...
NasdaqGS:SFM
NasdaqGS:SFMConsumer Retailing

How Investors May Respond To Sprouts Farmers Market (SFM) Securities Class Actions Challenging Its Growth Resilience Narrative

In recent months, multiple law firms have launched federal securities class action lawsuits against Sprouts Farmers Market, alleging false and misleading statements about its growth potential, customer resilience, and ability to withstand competitive and macroeconomic pressures between June 4, 2025 and October 29, 2025. The concentration of overlapping lawsuits raises the prospect of heightened legal, financial, and reputational risks for Sprouts, particularly if courts find that prior...
NasdaqGS:ZM
NasdaqGS:ZMSoftware

Does Zoom’s AI Expansion Justify Its 2025 Valuation After a 78.5% Five Year Slump?

If you are wondering whether Zoom Communications at around $87.91 is still a post pandemic fad or a quietly mispriced opportunity, this breakdown is for you if you are trying to figure out whether the current share price lines up with the company’s real value. Despite a brutal 5 year drawdown of about 78.5%, the stock has crept back into positive territory with a 7.8% gain year to date and a modest 3.9% rise over the last 12 months, which suggests sentiment may be slowly turning. Recently,...
NYSE:NEE
NYSE:NEEElectric Utilities

Does NextEra Energy Still Offer Upside After Its 2025 Renewables Expansion Push?

Wondering if NextEra Energy is still a smart buy at around $81 a share, or if the easy gains are already behind it? Let us unpack whether the current price leaves any real upside on the table. Over the last week the stock has edged up 2.1%, but it is still down 3.1% over the past month, even though it is up 13.6% year to date and 16.0% over the last year, and 23.7% over five years. This pattern hints at a steady long term compounding story rather than a speculative spike. Recent headlines...
NasdaqGS:INTU
NasdaqGS:INTUSoftware

Evaluating Intuit After Its Big AI Push and Strong Multi Year Price Gains

If you are wondering whether Intuit is still worth considering after its big run over the last few years, or if the easy money has already been made, you are not alone. The stock has inched up 2.1% over the last week and 1.0% over the past month, adding to a 76.4% gain over 3 years and 81.8% over 5 years, even though the 1 year return is slightly negative at -0.6%. Recent headlines have focused on Intuit doubling down on AI driven financial tools and expanding its ecosystem across...
NYSE:PATH
NYSE:PATHSoftware

UiPath (PATH): Reassessing Valuation After a 36% Three-Month Share Price Rally

UiPath (PATH) has quietly outperformed many software peers over the past 3 months, with the stock up about 36%, even after a choppy week that saw a pullback from recent highs. See our latest analysis for UiPath. That recent wobble comes after a strong run, with UiPath’s share price now at $16.09 and a solid 90 day share price return helping to offset a more modest 1 year total shareholder return. This suggests momentum is still broadly constructive as investors reassess its growth and...
NYSE:PBF
NYSE:PBFOil and Gas

PBF Energy (PBF): Revisiting Valuation After a Sharp Sell-Off and Strong Long-Term Returns

PBF Energy (PBF) shares have been under pressure recently, sliding over the past month and past 3 months, and that drawdown is making value focused investors recheck the long term story. See our latest analysis for PBF Energy. Zooming out, PBF Energy’s recent sell off, including a sharp 1 day share price return of minus 10.99 percent and a 30 day share price return of minus 31.67 percent, contrasts with a 5 year total shareholder return of 343.82 percent. This suggests long term investors...
NasdaqGS:RGLD
NasdaqGS:RGLDMetals and Mining

Royal Gold (RGLD) Is Up 7.4% After Dividend Hike Despite EPS Miss And Director Sale

Royal Gold recently reported record third-quarter 2025 revenue but missed earnings-per-share expectations and at the same time announced a 6% increase in its annual dividend for 2026, to be paid quarterly from January 16, 2026. A director share sale of about US$109,145 and a higher dividend alongside an earnings miss give investors mixed signals about near-term profitability and capital returns. Next, we’ll examine how Royal Gold’s record revenue but weaker earnings reshape its investment...
NYSE:ARE
NYSE:AREHealth Care REITs

Alexandria Real Estate Equities (ARE) Valuation After Q3 Miss, Dividend Cut and Mounting Investor Lawsuits

Alexandria Real Estate Equities (ARE) is back in the spotlight after a cluster of securities class action filings and investigations tied to its tough third quarter, impairment charge and 45% dividend cut. See our latest analysis for Alexandria Real Estate Equities. The latest wave of litigation, leadership changes and a new share repurchase program all sit against a steep reset, with the share price now at $46.97 and a roughly 52% year to date share price decline. Multi year total...
NasdaqCM:NNE
NasdaqCM:NNEElectrical

Nano Nuclear Energy (NNE): Assessing Valuation After New Microreactor Deals and FY 2025 Webcast Update Plans

NANO Nuclear Energy (NNE) has been drawing fresh attention after scheduling a Fiscal Year 2025 business update webcast and signing agreements to test its microreactors in real world data center and Texas facility settings. See our latest analysis for NANO Nuclear Energy. Those data center and Texas deployment plans seem to be shifting how investors are thinking about NANO Nuclear’s growth runway. The share price is at $32.31 after a 1 year to date share price return of 35.02 percent and a 1...
NasdaqGS:SLM
NasdaqGS:SLMConsumer Finance

Assessing SLM’s (SLM) Valuation After Analyst Downgrades Following Its Investor Forum

SLM (SLM) is back in focus after its recent Investor Forum prompted a wave of analyst revisions, with several firms trimming earnings forecasts and tempering their outlook on margins and operating costs. See our latest analysis for SLM. Those cautious revisions seem to be weighing on sentiment, with the share price at $26.84 and a slightly negative year to date share price return. However, the three and five year total shareholder returns of 75.9 percent and 141.0 percent suggest the longer...
NYSE:FRT
NYSE:FRTRetail REITs

Taking Another Look at Federal Realty (FRT) Valuation After Jefferies’ Upgrade and Recent Strategic Moves

Jefferies just upgraded Federal Realty Investment Trust (FRT) to Buy after the REIT ramped up its coastal footprint with acquisitions like Annapolis Town Center and Village Pointe, plus fresh board oversight from Joseph D. Fisher. See our latest analysis for Federal Realty Investment Trust. Even with this busy deal calendar, the stock’s 30 day share price return of just over 3 percent and slightly positive 3 year total shareholder return suggest momentum is only slowly rebuilding after a...